Chimerix (CMRX) News Today

$0.91
+0.03 (+3.39%)
(As of 04/22/2024 ET)
SourceHeadline
globenewswire.com logoChimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com - April 16 at 4:05 PM
MarketBeat logoChimerix (NASDAQ:CMRX) Stock Price Crosses Below 200 Day Moving Average of $1.00
americanbankingnews.com - April 16 at 3:38 AM
finance.yahoo.com logoWe Think Chimerix (NASDAQ:CMRX) Needs To Drive Business Growth Carefully
finance.yahoo.com - April 15 at 9:36 AM
finance.yahoo.com logoCMRX Apr 2024 1.000 put
finance.yahoo.com - March 16 at 2:02 PM
finance.yahoo.com logoCMRX Apr 2024 2.000 call
finance.yahoo.com - March 16 at 2:02 PM
finance.yahoo.com logoChimerix Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag
finance.yahoo.com - March 5 at 1:36 PM
seekingalpha.com logoChimerix, Inc. (CMRX) Q4 2023 Earnings Call Transcript
seekingalpha.com - March 2 at 1:58 AM
seekingalpha.com logoChimerix: Tackling A Strong Unmet Need With Promising Data
seekingalpha.com - March 1 at 8:58 PM
finance.yahoo.com logoChimerix, Inc. (NASDAQ:CMRX) Q4 2023 Earnings Call Transcript
finance.yahoo.com - March 1 at 9:44 AM
marketbeat.com logoChimerix (NASDAQ:CMRX) Earns "Buy" Rating from HC Wainwright
marketbeat.com - March 1 at 8:33 AM
markets.businessinsider.com logoBuy Rating Affirmed for Chimerix Amid Progress in Dordaviprone’s Phase III Study and Strong Financial Outlook
markets.businessinsider.com - February 29 at 7:19 PM
finanznachrichten.de logoChimerix, Inc.: Chimerix Reports Fourth Quarter and Year End 2023 Financial Results and Provides Operational Update
finanznachrichten.de - February 29 at 9:18 AM
finance.yahoo.com logoChimerix Inc Reports Fourth Quarter and Full-Year 2023 Financial Results
finance.yahoo.com - February 29 at 9:18 AM
globenewswire.com logoChimerix Reports Fourth Quarter and Year End 2023 Financial Results and Provides Operational Update
globenewswire.com - February 29 at 7:00 AM
benzinga.com logoPreview: Chimerix's Earnings
benzinga.com - February 28 at 2:55 PM
markets.businessinsider.com logoChimerix is about to announce its earnings — here's what Wall Street expects
markets.businessinsider.com - February 28 at 9:54 AM
finance.yahoo.com logoChimerix to Present at TD Cowen 44th Annual Health Care Conference
finance.yahoo.com - February 27 at 8:12 AM
finance.yahoo.com logoChimerix to Report Fourth Quarter and Year End 2023 Financial Results and Provide an Operational Update on February 29, 2024
finance.yahoo.com - February 22 at 8:30 AM
globenewswire.com logoChimerix to Report Fourth Quarter and Year End 2023 Financial Results and Provide an Operational Update on February 29, 2024
globenewswire.com - February 22 at 7:00 AM
finance.yahoo.com logoChimerix, Inc. (NASDAQ:CMRX) surges 24%; individual investors who own 43% shares profited along with institutions
finance.yahoo.com - February 18 at 9:28 AM
marketbeat.com logoChimerix (NASDAQ:CMRX) Shares Cross Below 200-Day Moving Average of $0.99
marketbeat.com - February 8 at 5:21 AM
msn.com logoLightning Could Strike Twice for Biotech Penny Stock Chimerix (NASDAQ:CMRX)
msn.com - January 9 at 1:03 PM
finance.yahoo.com logoChimerix Appoints Lisa Decker to Board of Directors
finance.yahoo.com - December 29 at 8:59 AM
finance.yahoo.com logoPositive Signs As Multiple Insiders Buy Chimerix Stock
finance.yahoo.com - December 14 at 8:36 AM
marketwatch.com logoChimerix Names Michelle LaSpaluto to Chief Financial Officer
marketwatch.com - December 4 at 9:37 AM
msn.com logoChimerix promotes Michelle Laspaluto to CFO
msn.com - December 4 at 9:37 AM
markets.businessinsider.com logoChimerix Appoints Michelle LaSpaluto As CFO
markets.businessinsider.com - December 4 at 9:37 AM
finance.yahoo.com logoChimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
finance.yahoo.com - November 24 at 10:09 AM
msn.com logoChimerix names Thomas Riga as Chief Operating and Commercial Officer
msn.com - November 16 at 9:38 AM
finance.yahoo.com logoChimerix Strengthens Executive Leadership Team with Appointment of Thomas Riga as Chief Operating and Commercial Officer
finance.yahoo.com - November 16 at 9:38 AM
finance.yahoo.com logoChimerix (NASDAQ:CMRX) shareholders have endured a 70% loss from investing in the stock five years ago
finance.yahoo.com - November 3 at 9:45 AM
finance.yahoo.com logoChimerix, Inc. (NASDAQ:CMRX) Q3 2023 Earnings Call Transcript
finance.yahoo.com - November 3 at 9:45 AM
finance.yahoo.com logoChimerix Inc (CMRX) Reports Q3 2023 Financial Results and Operational Updates
finance.yahoo.com - November 2 at 12:42 PM
msn.com logoChimerix GAAP EPS of -$0.27 misses by $0.04, revenue of $0.01M misses by $0.08M
msn.com - November 2 at 7:41 AM
finance.yahoo.com logoChimerix Reports Third Quarter 2023 Financial Results and Provides Operational Update
finance.yahoo.com - November 2 at 7:41 AM
morningstar.com logoChimerix Inc CMRX
morningstar.com - November 2 at 1:50 AM
benzinga.com logoEarnings Outlook For Chimerix
benzinga.com - November 1 at 8:50 PM
bizjournals.com logoPeak 25: Mike Andriole – CEO of Chimerix
bizjournals.com - October 26 at 10:18 PM
finance.yahoo.com logoChimerix to Report Third Quarter 2023 Financial Results and Provide an Operational Update on November 2, 2023
finance.yahoo.com - October 26 at 7:17 AM
finance.yahoo.com logoChimerix, Inc. (CMRX)
finance.yahoo.com - October 16 at 11:13 PM
msn.com logoChimerix: Dangerous Road, Thesis Intact
msn.com - September 8 at 7:44 AM
markets.businessinsider.com logoJonesTrading Sticks to Their Buy Rating for Chimerix (CMRX)
markets.businessinsider.com - August 18 at 5:44 PM
msn.com logoWedbush Reiterates Chimerix (CMRX) Outperform Recommendation
msn.com - August 17 at 10:33 PM
markets.businessinsider.com logo4 Analysts Have This to Say About Chimerix
markets.businessinsider.com - August 17 at 5:33 PM
markets.businessinsider.com logoH.C. Wainwright Remains a Buy on Chimerix (CMRX)
markets.businessinsider.com - August 16 at 5:36 PM
finance.yahoo.com logoChimerix Announces Data Highlighting Clinical Efficacy and Molecular Mechanisms of Response to ONC201 Treatment of H3 K27M-Mutant Diffuse Midline Gliomas Published in "Cancer Discovery"
finance.yahoo.com - August 16 at 5:36 PM
insidermonkey.com logo5 Best Quality Penny Stocks to Buy
insidermonkey.com - August 13 at 4:00 PM
investorplace.com logoCMRX Stock Warning! Smart Biotech Investors Will Avoid Chimerix Like the Plague.
investorplace.com - August 11 at 8:04 AM
markets.businessinsider.com logoRobert W. Baird Keeps Their Buy Rating on Chimerix (CMRX)
markets.businessinsider.com - August 8 at 11:27 AM
msn.com logoHC Wainwright & Co. Reiterates Chimerix (CMRX) Buy Recommendation
msn.com - August 4 at 5:53 PM
Get Chimerix News Delivered to You Automatically

Sign up to receive the latest news and ratings for CMRX and its competitors with MarketBeat's FREE daily newsletter.

Don’t Miss Out on the AI Gold Rush That’s Just Getting Started (Ad)

“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.

See how you can invest alongside him

CMRX Media Mentions By Week

CMRX Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CMRX
News Sentiment

0.51

0.49

Average
Medical
News Sentiment

CMRX News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CMRX Articles
This Week

2

1

CMRX Articles
Average Week

Get Chimerix News Delivered to You Automatically

Sign up to receive the latest news and ratings for CMRX and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:CMRX) was last updated on 4/22/2024 by MarketBeat.com Staff

From Our Partners